Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Chemicals Specialty Chemicals
Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Ceapro Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(106)
•••
Post by prophetoffactzon Feb 02, 2024 6:40pm
72 Views
Post# 35860607

AEZS test results

AEZS test resultsIn August AEZS expected the clinical trial to be fully enrolled by the end of the year: "...we established solid traction with our ongoing DETECT trial and are working towards meeting our goal of completing enrollment by year's end...”

It looks like each patient takes 1-4 months:

"The study will last for about 1 to 4 months, dependent on how close the visits are done."
Study Details | A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it is | ClinicalTrials.gov

Given we are now over one month into 2024 it would seem possible that the clinical trial has been completed. Clinical trial results could be the basis for signing a new North American licensing deal. They still must receive approval but the test has already been approved for adults.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities